Another possible controversy concerns who assumes the payment of damages to the affected people in case something goes wrong .
In both contracts, with AstraZeneca and CureVac, this responsibility is assumed by each Member State , as read, respectively, in Article 14.1 and Article 1.23.3., In which the pharmaceutical companies and “all their affiliates ”And subcontractors, in a long list, should be“ deemed exempt ”from any claims, including“ death, physical, emotional or mental injuries, illness, disability ”, loss of assets and income or legal costs.
These conditions are supposed to replicate in other contracts such as, for example, with Pfizer-Biontech. Only, nobody knows. They may be even more favorable to pharmaceutical companies.